跳至主要内容
临床试验/EUCTR2011-004787-30-DE
EUCTR2011-004787-30-DE进行中(未招募)1 期

Modification of the visual outcome after optic neuritis in CIS or MS by Gilenya® - MOVING

Charite Universitaetsmedizin Berlin0 个研究点目标入组 88 人开始时间: 2012年7月13日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • relapsing-remitting Multiple sclerosis (MS) or clinically isolated syndrom
  • Informed consent
  • First acute optic neuritis (ON) bout on qualifying eye within 30 days bevore screening
  • Age 18 - 55 years at screening
  • EDSS = 6,0
  • No MS bout except ON in the last 30 days before secreening
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 88
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Know contraindications againts therapy with Fingolimod (Gilenya®) or Interferon beta-1b Extavia®
  • pregnancy or lactation

研究者

发起方
Charite Universitaetsmedizin Berlin

相似试验